Mono Pharmacare Limited (NSE:MONOPHARMA)

Market Cap	441.71M
Revenue (ttm)	1.43B
Net Income (ttm)	28.70M
Shares Out	17.67M
EPS (ttm)	1.62
PE Ratio	15.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	68,000
Average Volume	19,000
Open	24.50
Previous Close	25.45
Day's Range	24.20 - 25.00
52-Week Range	22.10 - 42.80
Beta	n/a
RSI	49.07
Earnings Date	n/a

About Mono Pharmacare

Mono Pharmacare Limited engages in the marketing and distribution of pharmaceutical products in India. The company offers products in various categories, such as antibiotics, anti-fungal, anti cough- cold and anti-allergic, antacid and antiemetics, analgesic and antipyretic, nutraceuticals, skin care, antiseptic, cardiac and diabetics, cosmetics, etc. It also sells its pharmaceutical products under the DLS Export brand name. The company was founded in 1994 and is based in Ahmedabad, India.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1994
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MONOPHARMA

Financial Performance

In 2023, Mono Pharmacare's revenue was 1.22 billion, an increase of 269.41% compared to the previous year's 331.44 million. Earnings were 24.42 million, an increase of 158.84%.